Last Update: 12-31-1969

Number of Stocks:
Number of New Stocks:

Total Value: $0 Mil
Q/Q Turnover: %

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

past Portfolios

13F Filings

Portfolio DateNumber of StocksTotal Value (Mil)Number of New StocksQ/Q Turnover

13D/G Filings

Filing date :


  • The Silver Market in 2018 According to the Silver Institute

    The demand side of silver:

    The demand of silver is expected to grow in 2018, supported by the demand from industrial applications as electrification is increasing and by the worldwide demand for large and small scale solar panels. A positive contribution is also expected from the demand of jewelery, silver bar and coin.


  • Emirates Provides an Answer to A380 Jumbo Jet’s Future

    The European aerospace behemoth Airbus (EADSY) said that it might have to bring the production of its A380 Superjumbo plane to a close down after having received no orders of the same for the past two years. Since A380’s entry, Airbus has delivered 222 of them. The company, as of now, has unfulfilled orders of 95 A380s.

    Emirates signs A380 deal


  • Stocks That Fell to 3-Year Lows in the Week of Jan. 19

    General Electric Co. (NYSE:GE), Equity Residential (NYSE:EQR), HCP Inc. (NYSE:HCP), and Range Resources Corp. (NYSE:RRC) have declined to their three-year lows.

    General Electric Co. (NYSE:GE) declined to $16.26


  • Weekly Top Insider Buys Highlight for the Week of Jan. 19

    The largest Insider Buys this week were for JPMorgan Chase & Co. (NYSE:JPM), BlackRock Inc. (NYSE:BLK), Delta Air Lines Inc. (NYSE:DAL), and Signet Jewelers Ltd. (NYSE:SIG).

    JPMorgan Chase & Co. (NYSE:JPM): Director James S. Crown bought 7,280 shares


  • CVS and Gilead Sciences Hit the Casualty List

    Starving in the midst of plenty, some stocks got roughed up in the fourth quarter even as the market rose.

    Four of these stocks – CVS Inc., Gilead Sciences Inc., Owens & Minor Inc. and Argan Inc. – are on my Casualty List. It’s a roster I compile quarterly, containing stocks that have been wounded and that I think will recover.


  • 5 Low-P/E Tech Stocks Gurus Are Buying

    The tech sector broke out over the past year, beating the S&P 500 index by returning 36.4% to its 23.2%. But the sector has some laggards.

    The driving force behind tech’s gains were Nvidia Corp. (up 118%), PayPal Holdings Inc. (up 100.6%) and Micron Technology Inc. (up 97.1%). Value investors may shy away from the stocks, however, given their exorbitant prices and high price-earnings (P/E) ratios. The price-earnings ratio is 57.2 for Nvidia and 64.8 for PayPal. Micron breaks the mold by qualifying as being both one of the highest performers and having one of the lowest price-earnings ratios at 6.7.


  • US Market Indexes Gain on Friday

    U.S. market indexes were higher on Friday. The Dow Jones Industrial Average closed at 26,071.72 for a gain of 53.91 points or 0.21%. The S&P 500 Index closed at 2,810.30 for a gain of 12.27 points or 0.44%. The Nasdaq Composite closed at 7,336.38 for a gain of 40.33 points or 0.55%. The VIX Volatility Index was lower at 11.20 for a loss of -1.02 points or -8.35%.

    For the week, the Dow Jones gained 1.07%, the S&P 500 gained 0.53% and the Nasdaq Composite gained 0.50%.


  • Fledgling Biotech Company's Stock Surges

    Shares of fledgling biotech company Iovance Biotherapeutics Inc. (NASDAQ:IOVA) were up almost 12% in early afternoon trading as the company moves forward on some promising cancer immunotherapy treatments.

    The stock was trading at $10.75 a share on Friday afternoon, hours before market close. Industry watchers say there is no immediate explanation for the stock’s rally. However, news of the potential acquisition of one of its rivals may be a factor. Rumors have been swirling about ongoing talks between Seattle-based Juno Therapeutics (NASDAQ:JUNO) and pharma giant Celgene Corp. (NASDAQ:CELG).


  • Largest Insider Trades of the Week

    The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “January 2018” and All Insider Sales to “$5,000,000+.”

    According to these filters, company insiders made the following trades this week.


  • Jan. 19 Forum Update: 'Apple and DCF' Edition

    During the first three weeks of 2018, GuruFocus Value Investing Forum users shared discussions about Apple Inc. (NASDAQ:AAPL) and the discounted cash flow model.

    Apple announces U.S. expansion


  • IBM Falls Despite Reporting Growth for First Time in Almost 6 Years

    Technology company International Business Machines Corp. (NYSE:IBM) reported fourth-quarter and full-year 2017 earnings after the closing bell on Thursday, recording its first quarter of revenue growth in almost six years.

    The Armonk, New York-based company posted adjusted earnings per share of $5.18, topping Thomas Reuters’ estimates of $5.17. Quarterly revenue of $22.5 billion beat expectations of $22.06 billion and increased 4% from the prior-year quarter, ending the company’s prolonged 22-quarter streak of year-over-year revenue decline.


  • Here's Why the 2 Latest Hemispherx BioPharma Announcements Are Important

    Hemispherx BioPharma Inc. (HEB) had a strong start to 2017. The biotechnology stock gained more than 82% between Jan. 2 and Jan. 17 and, at time of writing, midsession on Friday, is trading around 20% off these highs having corrected into the end of the week.

    While this price action has been playing out, the company has announced two key developments, both of which relate to the production, commercialization and ongoing regulatory and development activity of its lead asset – a drug called Ampligen.


  • Larry Fink Preaches Activism-Lite


    Larry Fink, the chairman and CEO of BlackRock Inc. (NYSE:BLK) has just released his annual letter to CEOs of the corporations in which his firm invests.


  • 4 Stocks Move on Premarket Friday

    In Friday premarket trading, Schlumberger Ltd. (NYSE:SLB) lost about 3% after reporting financial results for the fourth quarter. The company registered earnings per share of 48 cents on revenue of $8.18 billion. The company beat by 4 cents per share and $50 million in revenue.

    Schlumberger Chairman and CEO Paal Kibsgaard was pleased with the 3% sequential growth in the trimester and with the pretax operating income which rose 9%. Sequential growth was fueled by strong activity in North America, Saudi Arabia and Latin America, offsetting declines in revenue in Europe, CIS and Africa.


  • IBM Falls Amid Financial Results

    U.S. stock markets are set to open flat on Friday after U.S. stocks ended lower yesterday, and reached an all-time high on Wednesday.

    Shares of International Business Machines Corp. (NYSE:IBMtraded lower on premarket Friday session on the back of the company posting its financial results for the fourth quarter of its fiscal 2017. For the trimester, IBM reported an annual net sales growth of 3.5% to $22.54 billion, while its profit advanced to $5.18 per share. Further, the results exceeded the analysts’ estimates by one cent in EPS and $490 million in revenue.


  • New Gold Falls Sharply

    New Gold Inc. (NGD) is falling on the American Stock Exchange.

    The gold stock is 8.6% down over the last three days of trading to a share price of $3.43 on Thursday. New Gold has underperformed the VanEck Vectors Gold Miners ETF (GDX) by 6.4% over the same span of time.


  • Eldorado Gold Drops

    Eldorado Gold Corp. (NYSE:EGO) continues down trending on the New York Stock Exchange.

    The gold stock lost 3.3% over the last two trading days to $1.33 per share despite the recent upgrade from Macquarie.


  • Weekly CFO Sells Highlight

    According to GuruFocus Insider Data, the recent CFO sells were: Allison Transmission Holdings Inc. (NYSE:ALSN) and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX).

    Allison Transmission Holdings Inc.


  • American Express Falls After Temporarily Suspending Buyback Program

    Financial services company American Express Co. (NYSE:AXP) reported fourth-quarter and full-year 2017 earnings after the closing bell on Thursday, announcing it will be temporarily suspending its share buyback program as a result of the Tax Cuts and Jobs Act.

    The New York City-based company posted adjusted earnings per share of $1.58, beating Thomas Reuters’ estimates of $1.54. Quarterly revenue of $8.84 billion beat expectations of $8.72 billion and increased 10% from the prior-year quarter due to record spending by card members.


  • GM Ducks $1 Billion Stock Payout

    A U.S. bankrupty judge has ruled a $1 billion stock payout from General Motors (NYSE:GM) to victims of auto accidents as a result of a faulty ignition switch is unenforceable.

    The ruling did little to affect the automaker's stock price. GM shares were trading at $43.86 a share, or down 0.39%, as the market closed on Thursday.


  • John Rogers' Ariel Funds 4th Quarter Commentary

    Quarter Ended December 31, 2017


  • Celebrating Another Year, Another Decade for Sidoxia

    Not only is New Year’s the time to celebrate the year that has just passed, but it is also the time to set new resolutions for the year to come. For financial markets, especially the stock market, 2017 was a special year of celebration. In addition to the S&P 500 index rejoicing a +19% gain, the more narrowly focused Dow Jones Industrial Average (consisting solely of 30 stocks) partied to an even more impressive +25% advance. Out of the three major stock indexes, the icing on the cake can be savored by the technology-heavy NASDAQ index, which soared +28% in 2017.

    Can the mojo of this festive bull market continue into its 10th year after the financial crisis? The short answer is “yes”, but there are numerous variables that can cause the performance gusts to swirl into a headwind or a tailwind. While many Americans are glued to the topic of politics and get caught up in the continual mudslinging, followers of Sidoxia Capital Management’s writings (see also Politics & Your Money) understand there are much more important factors impacting the long-term performance of your investments. More specifically, the following four factors I track on Sidoxia’s financial dashboard (Don’t Be a Fool) have continued to act as significant tailwinds for positive stock performance:


  • Dividend Growth Portfolio 2017 Year-End Letter to Investors

    For the full-year 2017, the Dividend Growth portfolio returned 8.5%, trailing the S&P 500’s 19.4% by a wide margin [returns figures calculated by Interactive Brokers].

    While I probably shouldn’t consider an 8.5% annual return a “failure,” it’s certainly frustrating to me to trail my benchmark like this. So, we’re going to take a long, hard look at what went right and what went wrong in 2017.


  • US Market Indexes Lower on Thursday

    U.S. market indexes were lower on Thursday. The Dow Jones Industrial Average closed at 26,017.81 for a loss of -97.84 points or -0.37%. The S&P 500 Index closed at 2,798.03 for a loss of -4.53 points or -0.16%. The Nasdaq Composite closed at 7,296.05 for a loss of -2.23 points or -0.03%. The VIX Volatility Index was higher for the day at 11.95 for a gain of 0.04 points or 0.34.

    Thursday’s market movers


  • Morgan Stanley Posts Fourth-Quarter Results

    The stock price for the sixth largest of the big banks was inching up just hours after the release of its fourth-quarter earnings report earlier this morning.

    Morgan Stanley (NYSE:MS) was trading at $55.55 per share on Thursday, up 0.27% after the bank reported net revenues of $9.5 billion for the quarter, compared to $9 billion for the same period a year ago. The information was released as part of the company’s earnings report and strategic update.


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat